Development of potent, selective cPLA2 inhibitors for targeting neuroinflammation in Alzheimer’s disease and other neurodegenerative disorders

Anastasiia Sadybekov(QB3), Hussein N. Yassine(University of Southern California)
npj Drug Discovery.
January 7, 2026
Cited by 1


Related Papers